Last checked at 26 Jul 2021 15:03
Ap19
FORM 8.3 - Amendment to Purchases
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1. KEY INFORMATION
| Name of person dealing (Note 1) | Barclays PLC. | |
| Company dealt in | WILLIS TOWERS WATSON PLC | |
| Class of relevant security to which the | ORD | |
| dealings being disclosed relate (Note 2) | ||
| Date of dealing | 22 July 2021 |
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)
| Class of relevant security: | ORD |
|
| ||
Long | Short | ||||
Number | (%) | Number | (%) | ||
(1) | Relevant securities |
|
|
|
|
1,851,475 | 1.44% | 246,722 | 0.19% | ||
|
|
|
| ||
(2) | Derivatives (other than options): |
|
|
|
|
72,359 | 0.06% | 227,408 | 0.18% | ||
|
|
|
| ||
(3) | Options and agreements to |
|
|
|
|
| purchase/sell: | 0 | 0.00% | 0 | 0.00% | |
|
|
|
| ||
| TOTAL: |
|
|
|
| |
1,923,834 | 1.49% | 474,130 | 0.37% | ||
|
|
|
| ||
(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)
Class of relevant security: | Long | Short | ||||
| Number |
| (%) | Number |
| (%) |
(1) Relevant securities |
|
| ||||
(2) Derivatives (other than options) |
|
| ||||
(3) Options and agreements to purchase/sell |
|
| ||||
Total |
|
| ||||
| ||||||
Ap20
1. DEALINGS (Note 4)
(a) Purchases and sales
| Purchase/sale | Number of relevant securities | Price per unit |
| Purchase | 2 | 226.2000 USD |
| Purchase | 4 | 226.5700 USD |
| Purchase | 22 | 226.1750 USD |
| Purchase | 50 | 226.5190 USD |
| Purchase | 60 | 226.6400 USD |
| Purchase | 100 | 226.8300 USD |
| Purchase | 188 | 226.8627 USD |
| Purchase | 191 | 226.2909 USD |
| Purchase | 204 | 226.3443 USD |
| Purchase | 273 | 226.7118 USD |
| Purchase | 300 | 226.3133 USD |
| Purchase | 540 | 226.7800 USD |
| Purchase | 547 | 226.7570 USD |
| Purchase | 863 | 226.8220 USD |
| Purchase | 1,149 | 226.1953 USD |
| Purchase | 1,242 | 225.9335 USD |
| Purchase | 1,663 | 226.7155 USD |
| Purchase | 1,762 | 226.4176 USD |
| Purchase | 2,097 | 226.5139 USD |
| Purchase | 2,673 | 226.7981 USD |
| Purchase | 3,099 | 226.7539 USD |
| Purchase | 5,099 | 226.3039 USD |
| Purchase | 7,567 | 226.3041 USD |
| Purchase | 7,654 | 226.3394 USD |
| Purchase | 13,734 | 226.3396 USD |
| Purchase | 13,777 | 226.3400 USD |
| Purchase | 35,036 | 226.2460 USD |
| Sale | 1 | 226.5300 USD |
| Sale | 1 | 226.8150 USD |
| Sale | 2 | 226.1050 USD |
| Sale | 5 | 226.4540 USD |
| Sale | 6 | 226.3341 USD |
| Sale | 7 | 226.3321 USD |
| Sale | 8 | 226.2687 USD |
| Sale | 10 | 226.1300 USD |
| Sale | 12 | 226.4479 USD |
| Sale | 14 | 226.3407 USD |
| Sale | 14 | 226.3200 USD |
| Sale | 17 | 226.2476 USD |
| Sale | 22 | 226.1750 USD |
| Sale | 51 | 226.1863 USD |
| Sale | 60 | 226.6400 USD |
| Sale | 100 | 226.3900 USD |
| Sale | 100 | 225.7020 USD |
| Sale | 200 | 226.1250 USD |
| Sale | 236 | 226.3408 USD |
| Sale | 384 | 226.4867 USD |
| Sale | 400 | 225.8925 USD |
| Sale | 472 | 226.3978 USD |
| Sale | 585 | 226.3854 USD |
| Sale | 794 | 226.3451 USD |
| Sale | 1,349 | 226.2581 USD |
| Sale | 1,447 | 226.3794 USD |
| Sale | 1,554 | 226.4281 USD |
| Sale | 1,581 | 226.4225 USD |
| Sale | 1,837 | 226.5238 USD |
| Sale | 2,549 | 226.1841 USD |
| Sale | 2,662 | 226.2305 USD |
| Sale | 4,825 | 226.4023 USD |
| Sale | 7,649 | 226.3044 USD |
| Sale | 7,654 | 226.3394 USD |
| Sale | 10,000 | 226.7673 USD |
| Sale | 19,794 | 226.3400 USD |
| Sale | 25,840 | 226.1988 USD |
(b) Derivatives transactions (other than options transactions)
Product name, e.g. CFD | Nature of transaction (Note 6) | Number of relevant securities (Note 7) | Price per unit (Note 5) |
|
|
|
|
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, e.g. call option | Writing, selling, purchasing, varying etc. | Number of securities to which the option relates (Note 7) | Exercise price | Type, e.g. American, European etc. | Expiry date | Option money paid/received per unit (Note 5) |
|
|
|
|
|
|
|
(ii) Exercising
Product name, e.g. call option | Number of securities | Exercise price per unit (Note 5) |
|
|
|
(d) Other dealings (including transactions in respect of new securities) (Note 4)
Nature of transaction (Note 8) | Details | Price per unit (if applicable) (Note 5) |
|
|
|
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
None
| Is a Supplemental Form 8 (Open Positions) attached? | NO |
| Date of disclosure: | 26 Jul 2021 |
| Contact name: | Large Holdings Regulatory Operations |
| Telephone number: | 020 3134 7213 |
| If a connected EFM, name of offeree/offeror with which connected | |
| If a connected EFM, state nature of connection |
View source version on businesswire.com: https://www.businesswire.com/news/home/20210726005519/en/
Copyright Business Wire 2021